Medicare Enrolled
Dr. Irina Rybalova, MD
Hematology & Oncology · Nyack, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rybalova from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rybalova?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rybalova
Dr. Irina Rybalova is a hematology & oncology specialist in Nyack, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Rybalova performed 1,991 Medicare services across 945 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rybalova received a total of $15,342 from 89 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rybalova is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 30% volume in NY
$15,342 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,991
Medicare services
Top 30% in NY for hematology & oncology
945
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
749 | $83 | $529 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
741 | $111 | $387 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
168 | $74 | $266 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
159 | $58 | $402 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
116 | $161 | $757 |
| New patient office visit, complex (60-74 min) | 34 | $162 | $1,053 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
24 | $129 | $744 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$15,342
Total received (2018-2024)
Avg $2,192/year across 7 years
Top 20% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
89
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,661 (82.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,389 (9.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,292 (8.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,734
2023
$3,220
2022
$1,732
2021
$487
2020
$1,049
2019
$3,771
2018
$2,350
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$477
Daiichi Sankyo Inc.
$272
PFIZER INC.
$190
Mirati Therapeutics, Inc.
$150
Lilly USA, LLC
$122
Eisai Inc.
$106
E.R. Squibb & Sons, L.L.C.
$100
Astellas Pharma US Inc
$96
AstraZeneca Pharmaceuticals LP
$91
Exelixis Inc.
$79
Alexion Pharmaceuticals, Inc.
$77
Takeda Pharmaceuticals U.S.A., Inc.
$73
TAIHO ONCOLOGY, INC.
$62
Ipsen Biopharmaceuticals, Inc
$60
BeiGene USA, Inc.
$55
GlaxoSmithKline, LLC.
$54
Incyte Corporation
$53
Blueprint Medicines Corporation
$50
SHIELD THERAPEUTICS INC
$49
Acrotech Biopharma Inc.
$48
GENZYME CORPORATION
$46
Merck Sharp & Dohme LLC
$46
Stemline Therapeutics Inc.
$46
Janssen Biotech, Inc.
$43
Bayer Healthcare Pharmaceuticals Inc.
$37
Gilead Sciences, Inc.
$35
JAZZ PHARMACEUTICALS INC.
$29
ABBVIE INC.
$28
Pharmacosmos Therapeutics Inc.
$28
ARRAY BIOPHARMA INC
$27
Regeneron Healthcare Solutions, Inc.
$21
Kyowa Kirin, Inc.
$20
Myriad Genetic Laboratories, Inc.
$20
Legend Biotech USA Inc.
$18
MorphoSys, US Inc.
$14
Tempus AI, Inc
$13
Top 3 companies account for 34.3% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,376
Novartis Pharmaceuticals Corporation
$1,293
Amgen Inc.
$1,125
Janssen Biotech, Inc.
$967
AstraZeneca Pharmaceuticals LP
$904
PFIZER INC.
$665
E.R. Squibb & Sons, L.L.C.
$576
Astellas Pharma US Inc
$548
Incyte Corporation
$481
Myriad Genetic Laboratories, Inc.
$457
Daiichi Sankyo Inc.
$377
Gilead Sciences, Inc.
$355
Pharmacyclics LLC, An AbbVie Company
$327
Merck Sharp & Dohme Corporation
$314
GENZYME CORPORATION
$305
Lilly USA, LLC
$287
Mirati Therapeutics, Inc.
$266
Genentech USA, Inc.
$257
Alexion Pharmaceuticals, Inc.
$249
Takeda Pharmaceuticals U.S.A., Inc.
$214
Celgene Corporation
$212
Eisai Inc.
$163
Exelixis Inc.
$151
Ipsen Biopharmaceuticals, Inc
$145
Janssen Pharmaceuticals, Inc
$144
TerSera Therapeutics LLC
$134
EMD Serono, Inc.
$132
Bayer Healthcare Pharmaceuticals Inc.
$123
Seagen Inc.
$116
Kyowa Kirin, Inc.
$110
EISAI INC.
$108
TAIHO ONCOLOGY, INC.
$101
COMSORT, Inc
$100
SANOFI-AVENTIS U.S. LLC
$100
Regeneron Healthcare Solutions, Inc.
$98
Bayer HealthCare Pharmaceuticals Inc.
$93
Merck Sharp & Dohme LLC
$84
Welch Allyn
$79
JAZZ PHARMACEUTICALS INC.
$77
Kite Pharma, Inc.
$73
Blueprint Medicines Corporation
$71
BeiGene USA, Inc.
$70
MorphoSys, US Inc.
$65
Taiho Oncology, Inc.
$57
GlaxoSmithKline, LLC.
$54
Helsinn Therapeutics (U.S.), Inc.
$53
Pharmacyclics LLC, an AbbVie Company
$51
Pharmacosmos Therapeutics Inc.
$51
TOLMAR Pharmaceuticals, Inc.
$50
SHIELD THERAPEUTICS INC
$49
Acrotech Biopharma Inc.
$48
Clovis Oncology, Inc.
$48
SERVIER PHARMACEUTICALS LLC
$47
Puma Biotechnology, Inc.
$46
PharmaEssentia USA Corporation
$46
Stemline Therapeutics Inc.
$46
AbbVie, Inc.
$43
Teva Pharmaceuticals USA, Inc.
$41
Coherus Biosciences Inc.
$40
Global Blood Therapeutics, Inc.
$39
SOBI, INC
$38
G1 Therapeutics, Inc.
$38
Shire North American Group Inc
$37
Apellis Pharmaceuticals, Inc.
$33
ARGON MEDICAL DEVICES, INC.
$33
CTI BioPharma Corp.
$29
ABBVIE INC.
$28
ARRAY BIOPHARMA INC
$27
Agios Pharmaceuticals, Inc.
$26
Sirtex Medical Inc
$26
Seattle Genetics, Inc.
$24
Dova Pharmaceuticals
$24
ImmunoGen, Inc.
$24
Servier Pharmaceuticals LLC
$21
Myovant Sciences Inc.
$18
Legend Biotech USA Inc.
$18
Emmaus Medical, Inc.
$17
Alnylam Pharmaceuticals Inc.
$17
Novocure Inc.
$16
Dendreon Pharmaceuticals LLC
$16
PORTOLA PHARMACEUTICALS, LLC
$16
Rigel Pharmaceuticals, Inc.
$16
Spectrum Pharmaceuticals Inc.
$16
AbbVie Inc.
$14
PUMA BIOTECHNOLOGY, INC.
$14
Tempus AI, Inc
$13
AMAG Pharmaceuticals, Inc.
$13
TESARO, Inc.
$13
Foundation Medicine, Inc.
$13
Top 3 companies account for 24.7% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · AFINITOR · AKYNZEO · ALUNBRIG · ANDEXXA · AYVAKIT · Abraxane · Alecensa · Aranesp · Avastin · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BOSULIF · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CAMZYOS · COSELA · CUVITRU · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELIGARD · ELIQUIS · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Elahere · Endari · Enhertu · Erleada · FASLODEX · FERAHEME · FOUNDATIONONE · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Halaven · Herceptin · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INVOKANA · IRESSA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYCHOICE CDX · MYRISK · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OJJAARA · ONPATTRO · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Optune · Orserdu · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANCUSO · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TLOK · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VARUBI · VERZENIO · VOTRIENT · VPRIV · VRAYLAR · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XT CDX · XTANDI · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
483
Per 100K population
142.5
County median income
$110,631
Nearest hospital
NYACK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rybalova is a clinical cardiology specialist, with above-average Medicare volume (top 30% in NY), with low-engagement industry engagement in the top 20% of NY peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rybalova experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rybalova performed 749 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rybalova receive payments from pharmaceutical companies?
Yes. Dr. Rybalova received a total of $15,342 from 89 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rybalova's costs compare to other hematology & oncology specialists in Nyack?
Dr. Rybalova's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rybalova) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Nyack
Browse hematology & oncology specialists in Nyack ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology